BioCentury on BioBusiness,
Emerging Company Profile
Warp Bio searching microbe genomes to systemize natural drug discovery
Related tables, figures and sidebars
Warp Drive: Warp speed ahead
Monday, August 12, 2013
Drive Bio LLC is seeking to discover microbial-generated natural
products with drug-like properties that will enable it to hit targets refractory
to standard small molecules and biologics. The company is using a proprietary
database of microbial genomes and search algorithm to systematically mine for
and Third Rock Ventures bet big on the approach when they launched Warp Drive
with $125 million in tranched funding comprising up to $75 million in equity
and up to an additional $50 million in non-equity funding from the pharma.
Greylock Partners participated in the equity round (see BioCentury, Jan 16,
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]